Lessons to learn from the patent cliff
Patents are running out on blockbuster drugs in an industry that makes up a third of Ireland's GDP, writes Tina-Marie O'Neill.
Over the past week, the world has been convulsed by the issue of the US fiscal cliff. But in Ireland, it is the so-called patent cliff that continues to concern policy-makers for the country's biggest export industry, pharmaceuticals.
The patents for many drugs produced in Ireland expire after 20 years. When this happens, generic manufacturers can produce and sell the drug at lower cost. The result is a sharp fall in revenue to the drug's...
Subscribe from just €1 for the first month!
With any subscription you will have access to
Unlimited multi-device access to our iPad, iPhone and Android Apps
Unlimited access to our eReader library
Exclusive daily insight and opinion seven days a week
Create alerts to never miss a subject that matters to you
Get access to exclusive offers for subscribers on gifts and experiences
Get content from Business Post, Business Post Magazines, Connected, Tatler and Food & Wine